Central Venous Catheters (CVCs) Market
Central Venous Catheters (CVCs) Market Analysis by Design (Multi-Lumen, Triple-Lumen, Double-Lumen, Single-Lumen), by Property (Non-antimicrobial Coated, Antimicrobial Coated), by Application, and by End User - Global Market Insights 2025 to 2035
Analysis of the Central Venous Catheters (CVCs) Market Covering 30+ Countries, Including Analysis of the U.S., Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea, and many more
Central Venous Catheters (CVCs) Market Outlook (2025 to 2035)
The global central venous catheters (CVCs) market is expected to grow from an estimated USD 1.54 billion in 2025 to USD 2.63 billion by 2035 at a CAGR rate of 5.5%.
The increasing trend of chronic disease prevalence, rising hospitalizations, and technological improvements in catheter design are the factors that are fueling demand for CVCs in both short-term and extended medical uses. With the increasing need for efficient fluid delivery, drug infusion, and hemodialysis access, medical centers are more and more adopting innovative and infection-resistant catheter technologies.
One of the leading growth drivers is the rise in the incidence of cardiovascular disease, cancer, and kidney disease, hence the need for extended vascular access for treatment such as chemotherapy, dialysis, and parenteral nutrition. Increasing ICU admissions and complex surgeries are also fueling demand for CVCs in ambulatory and hospital environments.
Moreover, technological innovations like antimicrobial-coated catheters, ultrasound-guided placement methods, and minimally invasive insertion techniques are improving safety and efficacy, minimizing complications such as catheter-related bloodstream infections (CRBSIs).
There are challenges of infection risk, thrombosis complications, and regulatory issues. CRBSIs continue to be a cause of concern, resulting in increased healthcare expenditure and more stringent compliance measures for catheter makers.
High procedure costs and the presence of competing vascular access devices, including peripherally inserted central catheters (PICCs) and implantable ports, can also hinder growth. It is of the utmost importance that these issues are resolved through improved biocompatibility, new coating materials, and rigorous medical professional training programs to reduce risk and promote uptake.
In the coming years, there will be steady growth driven by technology advancements, rising demand for critical care solutions, and innovations in infection control processes. Companies with a focus on biocompatible materials, next-generation coatings, and connectivity through digital platforms will remain competitive leaders in catering to the evolving needs of healthcare professionals as well as patients.
| Report Attributes | Details |
|---|---|
| Central Venous Catheters (CVCs) Market Size (2025E) | USD 1.54 billion |
| Central Venous Catheters (CVCs) Market Size (2035F) | USD 2.63 billion |
| Global Market Growth Rate (2025 to 2035) | 5.5% |
| U.S. Market Share (2025) | USD 1.52 billion |
| China Market Share (2035) | USD 2.89 billion |
| Key Companies Profiled | Amecath; Medtronic Plc; Smiths Medical, Inc.; Teleflex Incorporated; Vygon Ltd.; ZOLL Medical Corporation; AngioDynamics Inc.; Bactiguard AB; Becton, Dickinson and Company; COOK MEDICAL LLC; |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Shifts in the Market from 2020 to 2024 and Future Trends 2025 to 2035
From 2020 to 2024, the industry saw significant expansion due to the rising demand for critical care interventions, particularly in ICUs, oncology, and dialysis treatments. The rising hospitalization rate, especially during the COVID-19 pandemic, raised the need for CVCs to administer medications, fluids, and parenteral nutrition.
Companies such as Becton Dickinson, Teleflex, and Medtronic introduced antimicrobial-coated and heparin-coated catheters to reduce infection and thrombosis risks, focusing on hospital-acquired infection (HAI) prevention. Hospitals and healthcare institutions also focused on training programs to make CVC insertion safer and minimize complications.
From 2025 to 2035, technology will drive the next revolution of innovation in CVCs. The AI-driven catheter placement systems will minimize procedural risks, while biodegradable and antimicrobial-infused materials will prove to be useful in fighting off infections. The transition to home healthcare will quicken the improvement of self-administerable CVCs in patients receiving long-term chemotherapy or dialysis procedures.
Also, intelligent catheters with live monitoring will deliver real-time feedback on vein health, blood circulation, and any infections, which will allow preventive medical interventions. Regulatory advancements will also play a crucial role in shaping standardized CVC safety protocols worldwide.
A Comparative Market Shift Analysis (2020 to 2024 vs. 2025 to 2035)
| 2020 to 2024 | 2025 to 2035 |
|---|---|
| More patients with ICU stays, dialysis, and chemotherapy. | Increased home health care and self-care CVC demand. |
| Antimicrobial and heparin-coated catheters to minimize infection rates. | Entirely embedded antimicrobial materials with lasting effects. |
| Easy ultrasound-guided insertion procedures. | AI-supported, image-guided catheter placements for accuracy. |
| Silicone and polyurethane catheters with greater flexibility. | Biodegradable, infection-resistant materials for longer use. |
| Stronger safety measures for the reduction of catheter-associated infections. | Uniform global standards of CVC insertion and management. |
| The majority of applications were in specialty clinics and hospitals. | Shifting to home care and ambulatory facilities. |
| Coated catheters for the prevention of infection. | Smart CVCs with real-time monitoring and wireless transmission of data. |
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Analysis (2025 to 2035)
| Country | Estimated CAGR (2025 to 2035) |
|---|---|
| U.S. | 5.5% |
| UK | 4.8% |
| France | 4.6% |
| Germany | 4.9% |
| Italy | 4.5% |
| South Korea | 5.0% |
| Japan | 4.7% |
| China | 7.2% |
| Australia | 4.4% |
| New Zealand | 4.3% |
The U.S.
The U.S. accounts for a considerable portion of the industry, with a forecast CAGR of 5.5% from 2025 to 2035. The reason is the high prevalence of chronic conditions such as cancer, cardiovascular disease, and kidney diseases that need catheters for long-term drug delivery, chemotherapy, dialysis, and parenteral nutrition.
The country's advanced healthcare infrastructure, elevated health expenditure, and increasing utilization of technologically advanced catheterization procedures further drive growth. The key players aid the robust growth of sales by embracing relentless innovation, regulatory approval, and product upgrades. Specialized medical centers and high-grade research on vascular access devices are also aiding the increasing demand for Catheters in the U.S.
UK
The UK is anticipated to grow at 4.8% CAGR during the forecast period. The National Health Service (NHS) is a major contributor to the widespread usage of catheters among oncology, intensive care unit (ICU) patients, and patients requiring long-term vascular access. The increasing number of elderly patients and the increasing prevalence of chronic diseases are key drivers of demand.
Long-established medical device firms in the UK contribute significantly to the promotion of industry growth by providing quality catheter products. Furthermore, research and development of antimicrobial catheters to avoid catheter-associated bloodstream infections (CABIs) will contribute to growth.
France
France is expected to achieve a CAGR of 4.6% during 2025 to 2035. The country's well-established public healthcare infrastructure ensures easy access to sophisticated medical devices.
Increased surgeries, rising cancer incidences, and the expansion of home healthcare services are the major drivers for expansion. Local manufacturers and distributors contribute to the growth by offering a range of catheter solutions that meet the demands of healthcare practitioners. In addition, strict government regulations to ensure quality and patient safety have introduced innovations in bio-compatible and antimicrobial-coated catheters, which are now widely accepted in the industry.
Germany
Germany is expected to record a growth rate of 4.9% CAGR. The nation's emphasis on technological advancements in medical devices, robust healthcare infrastructure, and increasing hospital upgrade investments fuel the sales growth.
Increased hospitalizations for chronic disease management propel demand for catheters. Local producers enjoy a good industry presence in the form of innovative catheter products. The increasing growth of peripherally inserted central catheters (PICCs) and tunneled catheters in long-term patient treatment is set to propel the industry.
Italy
Italy is set to grow at a CAGR of 4.5% between 2025 and 2035. The aging population and consequent rise in chronic conditions such as kidney failure and cancer propel the demand for central venous catheters. The availability of universal healthcare coverage in Italy encourages easier adoption of advanced medical devices.
Moreover, the increasing popularity of minimally invasive vascular access is propelling the growth. Local distributors and producers also support the dynamics by providing quality products on the matter of catheters at lower costs.
South Korea
South Korea's Central Venous Catheters market will grow at a CAGR of 5.0% through the forecast period. The fast technological growth occurring in healthcare technology in the region, coupled with rising investments in medical infrastructure, supports the use of central venous catheters.
The aging population, coupled with increasing long-term ailments such as cancer, further supports demand. Local companies dominate the supply of various catheter solutions. Government initiatives to promote medical device manufacturing and export capabilities also support expansion.
Japan
Japan shall experience a CAGR of 4.7% between 2025 and 2035. Japan's super-aging society leads to a higher prevalence of chronic diseases, necessitating the use of central venous catheters. Healthcare innovation in Japan is maintained with dedication, and stringent quality standards contribute to industry development.
Domestic manufacturers contribute significantly with the provision of advanced catheter products tailored to suit Japanese healthcare professional's requirements. Furthermore, the application of antimicrobial catheters for infection prevention purposes is increasingly popular among hospitals and clinics.
China
China will experience robust growth at a CAGR of 7.2% during the forecast period. Growth is driven by the rapid development of urban areas, expansion of the middle-class population, and increasing healthcare spending.
The spread of chronic diseases and government initiatives to improve access to healthcare contribute to growth further. Local manufacturers are becoming key players, making local sales more robust. The high growth rate is due to increased investment in hospital infrastructure and the growth of private healthcare services.
Australia
Australia is projected to grow by 4.4% per annum between 2025 and 2035. With a strong, well-developed system of healthcare and stringent levels of medical treatment, it is easy to adopt central venous catheters. Aside from expanding demand due to chronic disease, a progressively geriatric population drives demand.
Foreign firms that provide medical devices with a healthy presence in Australia help significantly to stay in touch with high-quality catheter products. The increased focus on infection prevention through improved catheter design is expected to drive growth further.
New Zealand
New Zealand is expected to grow at a CAGR of 4.3% during the forecast period. The country's national public healthcare system ensures access to essential medical devices like central venous catheters.
An increasing burden of chronic diseases and a need to improve healthcare services drive growth. Collaborations with international medical device companies guarantee the availability of advanced catheter products. The introduction of home-based catheter care solutions is also expected to contribute to development.
Segment-wise Analysis
By Design
Different types of catheter designs would drive the CVC industry in 2025, with multi-lumen and triple-lumen catheters having some lead. With a share of 40%, multi-lumen catheters will lead, followed by triple-lumen catheters with 25%, indicating an emerging need for vascular access solutions efficiently used in critical care settings.
Multi-lumen catheter versions have dominated due to their multiple uses and settings: the intensive care unit (ICU), emergency rooms, and oncology treatment. These catheters allow the slow delivery of various medications, blood products, and parenteral nutrition, decreasing the number of insertions in patients undergoing treatment as a whole.
Top players, namely, Teleflex, Becton Dickinson (BD), and Medtronic, are innovating in infection-resistant coatings, antimicrobial properties, and ultrasound-guided placement methods for the safety of their patients and lessening procedure-associated complications like catheter-related bloodstream infections (CRBSIs).
The surging demand for multi-lumen central venous catheters used in long-term IV therapy and dialysis is due to rising incidences of chronic diseases such as cancer and renal disorders.
Triple-lumen catheters account for about 25% of this share because they are suited for ICUs and surgical locations where multiple access points are required for drug infusion, hemodynamic monitoring, and blood sampling. These catheters are utilized mainly for procedures requiring precise fluid management and continuous monitoring of central venous pressure (CVP).
Other companies such as Edwards Lifesciences, Cook Medical, and ICU Medical continue to focus on enhancing biocompatibility, ease of insertion, and durability strategies to accommodate the growing public demand for safer and more efficient vascular access solutions.
By Property
In 2025, the industry is expected to be segmented based on catheter properties, with non-antimicrobial coated catheters holding a 55% share, while antimicrobial coated catheters account for 45%
The sales of non-antimicrobial-coated catheters continue to flourish. Their widespread acceptance in almost all medical procedures, combined with lower pricing than their antimicrobial counterparts, is defining their success.
Non-coated CVCs are preferred in many situations because of their widespread usage in short-term hospital stays, emergency medicine, and surgery, where infection risk is very low, or other enhanced preventive strategies, such as aseptic techniques of insertion, have been employed.
Major manufacturers such as Becton Dickinson (BD), Teleflex, and Cook Medical manufacture non-coated CVCs in extensive ranges; thus, the target of these products lies primarily with cost-conscious hospitals and clinics. Nevertheless, growing concerns about the incidence of catheter-related bloodstream infections (CRBSIs) lend renewed interest to antimicrobial options.
About 45% of the share is accounted for by antimicrobial-coated catheters, with their increasing recognition for reducing infection rates and making the patient environment safer. Such catheters are impregnated with multiple antimicrobial agents, the most common ones being silver, chlorhexidine, and minocycline rifampin.
They prevent bacterial colonization, thereby decreasing the chances of CRBSIs, which is a major concern for ICUs and patients on long-term intravenous therapy. Edwards Lifesciences, Medtronic, and ICU Medical are companies active in the industry with investments toward developing new advanced coating technologies to make these catheters work efficiently.
The increasing incidence of multidrug-resistant (MDR) infections and ever-increasing adherence to hospital infection control protocols are significant reasons attributed to the growing demand for antimicrobial-coated CVCs.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Competitive Outlook
The growth of the industry is steady owing to rising chronic disease burden, demand for long vascular access, and advancements in catheter technology. Widely used in the ICU, oncology management, dialysis procedures, and parenteral nutrition, CVCs remain a key component of modern healthcare systems. Further, the sales expansion is also aided by the increasing geriatric populace and the growing cancer and kidney disorder incidence.
Manufacturers are concentrating on the production of antimicrobial and heparin-treated CVCs to reduce catheter-related bloodstream infections (CRBSIs). Improvements in technology, including ultrasound-guided catheter insertion and bioresorbable materials, will ensure patient safety and procedural efficiency. Dual-lumen and triple-lumen catheters for multi-purpose use in critically ill patients are also gaining sales momentum.
Preference is gaining strongly for minimally invasive procedures and catheter-based interventions, which has driven the demand for innovative catheter designs. The guidelines related to infection control are being made more stringent by the FDA and EMA, thus forcing manufacturers to do more in terms of sterility and biocompatibility. The growing usage of outpatient care and home-based treatments is bringing more and more usage of PICCs as alternatives to traditional CVCs.
The companies are investing in the research and development of catheters in terms of safety, permanence, and ease of insertion. Strategic partnerships with medical institutions to provide training programs on central venous catheter (CVC) placement and maintenance are making the use of CVCs widespread. Additionally, there is a growing focus on biodegradable and environmentally friendly catheters as the medical disposables industry becomes increasingly concerned with sustainability.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Medtronic Plc | 22 |
| Becton, Dickinson, and Company | 18 |
| Teleflex Incorporated | 15 |
| Smiths Medical, Inc. | 12 |
| AngioDynamics Inc. | 10 |
| Other Companies | 23 |
Key Company Offerings and Activities
| Company Name | Key Offerings/Activities |
|---|---|
| Medtronic Plc | Offers innovative CVCs with antimicrobial protection and heparin coating for infection control. |
| Becton, Dickinson and Company | Provides a broad range of CVCs, including antimicrobial and hemodialysis catheters. |
| Teleflex Incorporated | Specializes in Arrow CVCs with advanced safety features and infection-prevention coatings. |
| Smiths Medical, Inc. | Develops multi-lumen CVCs for critical care applications, emphasizing patient safety. |
| AngioDynamics Inc. | Focuses on bioresorbable and long-term vascular access devices with advanced coating technologies. |
Key Company Insights
Medtronic Plc (22%)
A key leader in CVC technology, Medtronic emphasizes infection prevention and catheter longevity through advanced antimicrobial and heparin-coated solutions. The company is also investing in catheter-based diagnostic technologies.
Becton, Dickinson and Company (18%)
BD’s portfolio includes antimicrobial and antimicrobial-impregnated CVCs designed to reduce bloodstream infections. Its strong global distribution network gives it a competitive edge.
Teleflex Incorporated (15%)
Teleflex’s Arrow brand is widely used for critical care, with patented antimicrobial technology and safety catheter insertion kits to minimize complications.
Smiths Medical, Inc. (12%)
Smiths Medical develops multi-lumen CVCs with an emphasis on precision and safety. The company’s focus on patient-centric designs strengthens its industry presence.
AngioDynamics Inc. (10%)
AngioDynamics specializes in vascular access devices, including innovative bioresorbable catheters designed for improved patient outcomes and reduced clotting risks.
Other Key Players (23% Combined)
- Amecath
- Vygon Ltd.
- ZOLL Medical Corporation
- Bactiguard AB
- COOK MEDICAL LLC
Key Players
- Medtronic Plc
- Becton, Dickinson and Company
- Teleflex Incorporated
- Smiths Medical, Inc.
- AngioDynamics Inc.
- Amecath
- Vygon Ltd.
- ZOLL Medical Corporation
- Bactiguard AB
- COOK MEDICAL LLC
Segmentation
By Design
The segmentation is into Multi-Lumen, Triple-Lumen, Double-Lumen, and Single-Lumen.
By Property
The segmentation is into non-antimicrobial coating and antimicrobial coating.
By Application
The segmentation is into Jugular Vein, Femoral Vein, and Subclavian Vein applications.
By End User
The segmentation is into Hospitals, Ambulatory Surgical Centers, and Others.
By Region
The segmentation is into North America, Europe, East Asia, South Asia, Latin America, the Middle East & Africa (MEA), and Oceania.
Table of Content
- 1. Executive Summary
- 2. Market Overview
- 3. Market Background
- 4. Global Market Pricing Analysis
- 5. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035)
- 6. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Design
- 6.1. Multi-Lumen
- 6.2. Triple-Lumen
- 6.3. Double-Lumen
- 6.4. Single-Lumen
- 7. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Property
- 7.1. Non-antimicrobial Coated
- 7.2. Antimicrobial Coated
- 8. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Application
- 8.1. Jugular Vein
- 8.2. Femoral Vein
- 8.3. Subclavian Vein
- 9. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by End User
- 9.1. Hospitals
- 9.2. Ambulatory Surgical Centers
- 9.3. Others
- 10. Global Market Analysis (2020 to 2024) and Forecast (2025 to 2035), by Region
- 10.1. North America
- 10.2. Europe
- 10.3. East Asia
- 10.4. South Asia
- 10.5. Latin America
- 10.6. Middle East & Africa (MEA)
- 10.7. Oceania
- 11. North America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia Market Analysis and Forecast
- 15. Latin America Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Oceania Market Analysis and Forecast
- 18. Global Market Analysis Key Countries
- 19. Competition Landscape
- 20. Competition Analysis
- 20.1. Amecath
- 20.2. Medtronic Plc
- 20.3. Smiths Medical, Inc.
- 20.4. Teleflex Incorporated
- 20.5. Vygon Ltd.
- 20.6. ZOLL Medical Corporation
- 20.7. AngioDynamics Inc.
- 20.8. B. Braun Melsungen AG
- 20.9. Bactiguard AB
- 20.10. Becton, Dickinson and Company
- 20.11. COOK MEDICAL LLC
- 20.12. Edwards Lifesciences Corporation
- 20.13. ICU Medical, Inc.
- 20.14. Insung Medical Co. Ltd.
- 21. Appendix
- 22. Definitions of Analytical Frameworks
- 23. Sources and References
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (Units), by Design, 2025 to 2035
Table 02: Global Market Value (US$ Mn), by Design, 2025 to 2035
Table 03: Global Market Volume (Units), by Property, 2025 to 2035
Table 04: Global Market Value (US$ Mn), by Property, 2025 to 2035
Table 05: Global Market Volume (Units), by Application, 2025 to 2035
Table 06: Global Market Value (US$ Mn), by Application, 2025 to 2035
Table 07: Global Market Volume (Units), by End User, 2025 to 2035
Table 08: Global Market Value (US$ Mn), by End User, 2025 to 2035
Table 09: Global Market Volume (Units), by Region, 2025 to 2035
Table 10: Global Market Value (US$ Mn), by Region, 2025 to 2035
Table 11: North America Market Volume (Units), by Design, 2025 to 2035
Table 12: North America Market Value (US$ Mn), by Design, 2025 to 2035
Table 13: North America Market Volume (Units), by Property, 2025 to 2035
Table 14: North America Market Value (US$ Mn), by Property, 2025 to 2035
Table 15: North America Market Volume (Units), by Application, 2025 to 2035
Table 16: North America Market Value (US$ Mn), by Application, 2025 to 2035
Table 17: North America Market Volume (Units), by End User, 2025 to 2035
Table 18: North America Market Value (US$ Mn), by End User, 2025 to 2035
Table 19: North America Market Volume (Units), by Country, 2025 to 2035
Table 20: North America Market Value (US$ Mn), by Country, 2025 to 2035
Table 21: Europe Market Volume (Units), by Design, 2025 to 2035
Table 22: Europe Market Value (US$ Mn), by Design, 2025 to 2035
Table 23: Europe Market Volume (Units), by Property, 2025 to 2035
Table 24: Europe Market Value (US$ Mn), by Property, 2025 to 2035
Table 25: Europe Market Volume (Units), by Application, 2025 to 2035
Table 26: Europe Market Value (US$ Mn), by Application, 2025 to 2035
Table 27: Europe Market Volume (Units), by End User, 2025 to 2035
Table 28: Europe Market Value (US$ Mn), by End User, 2025 to 2035
Table 29: Europe Market Volume (Units), by Country, 2025 to 2035
Table 30: Europe Market Value (US$ Mn), by Country, 2025 to 2035
Table 31: East Asia Market Volume (Units), by Design, 2025 to 2035
Table 32: East Asia Market Value (US$ Mn), by Design, 2025 to 2035
Table 33: East Asia Market Volume (Units), by Property, 2025 to 2035
Table 34: East Asia Market Value (US$ Mn), by Property, 2025 to 2035
Table 35: East Asia Market Volume (Units), by Application, 2025 to 2035
Table 36: East Asia Market Value (US$ Mn), by Application, 2025 to 2035
Table 37: East Asia Market Volume (Units), by End User, 2025 to 2035
Table 38: East Asia Market Value (US$ Mn), by End User, 2025 to 2035
Table 39: East Asia Market Volume (Units), by Country, 2025 to 2035
Table 40: East Asia Market Value (US$ Mn), by Country, 2025 to 2035
Table 41: South Asia Market Volume (Units), by Design, 2025 to 2035
Table 42: South Asia Market Value (US$ Mn), by Design, 2025 to 2035
Table 43: South Asia Market Volume (Units), by Property, 2025 to 2035
Table 44: South Asia Market Value (US$ Mn), by Property, 2025 to 2035
Table 45: South Asia Market Volume (Units), by Application, 2025 to 2035
Table 46: South Asia Market Value (US$ Mn), by Application, 2025 to 2035
Table 47: South Asia Market Volume (Units), by End User, 2025 to 2035
Table 48: South Asia Market Value (US$ Mn), by End User, 2025 to 2035
Table 49: South Asia Market Volume (Units), by Country, 2025 to 2035
Table 50: South Asia Market Value (US$ Mn), by Country, 2025 to 2035
Table 51: Latin America Market Volume (Units), by Design, 2025 to 2035
Table 52: Latin America Market Value (US$ Mn), by Design, 2025 to 2035
Table 53: Latin America Market Volume (Units), by Property, 2025 to 2035
Table 54: Latin America Market Value (US$ Mn), by Property, 2025 to 2035
Table 55: Latin America Market Volume (Units), by Application, 2025 to 2035
Table 56: Latin America Market Value (US$ Mn), by Application, 2025 to 2035
Table 57: Latin America Market Volume (Units), by End User, 2025 to 2035
Table 58: Latin America Market Value (US$ Mn), by End User, 2025 to 2035
Table 59: Latin America Market Volume (Units), by Country, 2025 to 2035
Table 60: Latin America Market Value (US$ Mn), by Country, 2025 to 2035
Table 61: Middle East and Africa Market Volume (Units), by Design, 2025 to 2035
Table 62: Middle East and Africa Market Value (US$ Mn), by Design, 2025 to 2035
Table 63: Middle East and Africa Market Volume (Units), by Property, 2025 to 2035
Table 64: Middle East and Africa Market Value (US$ Mn), by Property, 2025 to 2035
Table 65: Middle East and Africa Market Volume (Units), by Application, 2025 to 2035
Table 66: Middle East and Africa Market Value (US$ Mn), by Application, 2025 to 2035
Table 67: Middle East and Africa Market Volume (Units), by End User, 2025 to 2035
Table 68: Middle East and Africa Market Value (US$ Mn), by End User, 2025 to 2035
Table 69: Middle East and Africa Market Volume (Units), by Country, 2025 to 2035
Table 70: Middle East and Africa Market Value (US$ Mn), by Country, 2025 to 2035
Table 71: Oceania Market Volume (Units), by Design, 2025 to 2035
Table 72: Oceania Market Value (US$ Mn), by Design, 2025 to 2035
Table 73: Oceania Market Volume (Units), by Property, 2025 to 2035
Table 74: Oceania Market Value (US$ Mn), by Property, 2025 to 2035
Table 75: Oceania Market Volume (Units), by Application, 2025 to 2035
Table 76: Oceania Market Value (US$ Mn), by Application, 2025 to 2035
Table 77: Oceania Market Volume (Units), by End User, 2025 to 2035
Table 78: Oceania Market Value (US$ Mn), by End User, 2025 to 2035
Table 79: Oceania Market Volume (Units), by Country, 2025 to 2035
Table 80: Oceania Market Value (US$ Mn), by Country, 2025 to 2035
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Fig 01: Global Market Volume (Units), Value (US$ Thousand) and Y-o-Y Growth, 2025 to 2035
Fig 02: Global Absolute $ Historical Market (2020 to 2024) and Absolute $ Opportunity (2025 to 2035), US$ Mn
Fig 03: Global Absolute Historical Volume Market (2020 to 2024) and Absolute Volume Opportunity (2025 to 2035), Units
Fig 04: Global Market Value Y-o-Y Growth and Forecast, 2025 to 2035
Fig 05: Global Market Incremental $ Opportunity (US$ Thousand), 2025 to 2035
Fig 06: Global Market Share, By Design to 2025 to 2035
Fig 07: Global Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 08: Global Market Attractiveness Index, By Design to 2025 to 2035
Fig 09: Global Market Share, By Property to 2025 to 2035
Fig 10: Global Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 11: Global Market Attractiveness Index, By Property to 2025 to 2035
Fig 12: Global Market Share, By Application to 2025 to 2035
Fig 13: Global Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 14: Global Market Attractiveness Index, By Application to 2025 to 2035
Fig 15: Global Market Share, By End User to 2025 to 2035
Fig 16: Global Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 17: Global Market Attractiveness Index, By End User to 2025 to 2035
Fig 18: Global Market Share, by Region to 2025 to 2035
Fig 19: Global Market Y-o-Y Growth Projections, by Region to 2025 to 2035
Fig 20: Global Market Attractiveness Index, by Region to 2025 to 2035
Fig 21: North America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 22: Y-o-Y Growth Comparison of Market: North America Vs North America Countries Vs North America Average
Fig 23: North America Market Share, By Design to 2025 to 2035
Fig 24: North America Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 25: North America Market Attractiveness Index, By Design to 2025 to 2035
Fig 26: North America Market Share, By Property to 2025 to 2035
Fig 27: North America Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 28: North America Market Attractiveness Index, By Property to 2025 to 2035
Fig 29: North America Market Share, By Application to 2025 to 2035
Fig 30: North America Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 31: North America Market Attractiveness Index, By Application to 2025 to 2035
Fig 32: North America Market Share, By End User to 2025 to 2035
Fig 33: North America Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 34: North America Market Attractiveness Index, By End User to 2025 to 2035
Fig 35: North America Market Share, By Country to 2025 to 2035
Fig 36: North America Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 37: North America Market Attractiveness Index, By Country to 2025 to 2035
Fig 38: Europe Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 39: Y-o-Y Growth Comparison of Market: Europe Vs Europe Countries Vs Europe Average
Fig 40: Europe Market Share, By Design to 2025 to 2035
Fig 41: Europe Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 42: Europe Market Attractiveness Index, By Design to 2025 to 2035
Fig 43: Europe Market Share, By Property to 2025 to 2035
Fig 44: Europe Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 45: Europe Market Attractiveness Index, By Property to 2025 to 2035
Fig 46: Europe Market Share, By Application to 2025 to 2035
Fig 47: Europe Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 48: Europe Market Attractiveness Index, By Application to 2025 to 2035
Fig 49: Europe Market Share, By End User to 2025 to 2035
Fig 50: Europe Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 51: Europe Market Attractiveness Index, By End User to 2025 to 2035
Fig 52: Europe Market Share, By Country to 2025 to 2035
Fig 53: Europe Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 54: Europe Market Attractiveness Index, By Country to 2025 to 2035
Fig 55: East Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 56: Y-o-Y Growth Comparison of Market: East Asia Vs East Asia Countries Vs East Asia Average
Fig 57: East Asia Market Share, By Design to 2025 to 2035
Fig 58: East Asia Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 59: East Asia Market Attractiveness Index, By Design to 2025 to 2035
Fig 60: East Asia Market Share, By Property to 2025 to 2035
Fig 61: East Asia Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 62: East Asia Market Attractiveness Index, By Property to 2025 to 2035
Fig 63: East Asia Market Share, By Application to 2025 to 2035
Fig 64: East Asia Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 65: East Asia Market Attractiveness Index, By Application to 2025 to 2035
Fig 66: East Asia Market Share, By End User to 2025 to 2035
Fig 67: East Asia Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 68: East Asia Market Attractiveness Index, By End User to 2025 to 2035
Fig 69: East Asia Market Share, By Country to 2025 to 2035
Fig 70: East Asia Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 71: East Asia Market Attractiveness Index, By Country to 2025 to 2035
Fig 72: South Asia Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 73: Y-o-Y Growth Comparison of Market: South Asia Vs South Asia Countries Vs South Asia Average
Fig 74: South Asia Market Share, By Design to 2025 to 2035
Fig 75: South Asia Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 76: South Asia Market Attractiveness Index, By Design to 2025 to 2035
Fig 77: South Asia Market Share, By Property to 2025 to 2035
Fig 78: South Asia Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 79: South Asia Market Attractiveness Index, By Property to 2025 to 2035
Fig 80: South Asia Market Share, By Application to 2025 to 2035
Fig 81: South Asia Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 82: South Asia Market Attractiveness Index, By Application to 2025 to 2035
Fig 83: South Asia Market Share, By End User to 2025 to 2035
Fig 84: South Asia Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 85: South Asia Market Attractiveness Index, By End User to 2025 to 2035
Fig 86: South Asia Market Share, By Country to 2025 to 2035
Fig 87: South Asia Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 88: South Asia Market Attractiveness Index, By Country to 2025 to 2035
Fig 89: Latin America Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 90: Y-o-Y Growth Comparison of Market: Latin America Vs Latin America Countries Vs Latin America Average
Fig 91: Latin America Market Share, By Design to 2025 to 2035
Fig 92: Latin America Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 93: Latin America Market Attractiveness Index, By Design to 2025 to 2035
Fig 94: Latin America Market Share, By Property to 2025 to 2035
Fig 95: Latin America Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 96: Latin America Market Attractiveness Index, By Property to 2025 to 2035
Fig 97: Latin America Market Share, By Application to 2025 to 2035
Fig 98: Latin America Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 99: Latin America Market Attractiveness Index, By Application to 2025 to 2035
Fig 100: Latin America Market Share, By End User to 2025 to 2035
Fig 101: Latin America Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 102: Latin America Market Attractiveness Index, By End User to 2025 to 2035
Fig 103: Latin America Market Share, By Country to 2025 to 2035
Fig 104: Latin America Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 105: Latin America Market Attractiveness Index, By Country to 2025 to 2035
Fig 106: MEA Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 107: Y-o-Y Growth Comparison of Market: MEA Vs MEA Countries Vs MEA Average
Fig 108: MEA Market Share, By Design to 2025 to 2035
Fig 109: MEA Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 110: MEA Market Attractiveness Index, By Design to 2025 to 2035
Fig 111: MEA Market Share, By Property to 2025 to 2035
Fig 112: MEA Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 113: MEA Market Attractiveness Index, By Property to 2025 to 2035
Fig 114: MEA Market Share, By Application to 2025 to 2035
Fig 115: MEA Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 116: MEA Market Attractiveness Index, By Application to 2025 to 2035
Fig 117: MEA Market Share, By End User to 2025 to 2035
Fig 118: MEA Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 119: MEA Market Attractiveness Index, By End User to 2025 to 2035
Fig 120: MEA Market Share, By Country to 2025 to 2035
Fig 121: MEA Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 122: MEA Market Attractiveness Index, By Country to 2025 to 2035
Fig 123: Oceania Market Value (US$ Thousand), Volume (Units) Forecast and Analysis, 2025 to 2035
Fig 124: Y-o-Y Growth Comparison of Market: Oceania Vs Oceania Countries Vs Oceania Average
Fig 125: Oceania Market Share, By Design to 2025 to 2035
Fig 126: Oceania Market Y-o-Y Growth Projections, By Design to 2025 to 2035
Fig 127: Oceania Market Attractiveness Index, By Design to 2025 to 2035
Fig 128: Oceania Market Share, By Property to 2025 to 2035
Fig 129: Oceania Market Y-o-Y Growth Projections, By Property to 2025 to 2035
Fig 130: Oceania Market Attractiveness Index, By Property to 2025 to 2035
Fig 131: Oceania Market Share, By Application to 2025 to 2035
Fig 132: Oceania Market Y-o-Y Growth Projections, By Application to 2025 to 2035
Fig 133: Oceania Market Attractiveness Index, By Application to 2025 to 2035
Fig 134: Oceania Market Share, By End User to 2025 to 2035
Fig 135: Oceania Market Y-o-Y Growth Projections, By End User to 2025 to 2035
Fig 136: Oceania Market Attractiveness Index, By End User to 2025 to 2035
Fig 137: Oceania Market Share, By Country to 2025 to 2035
Fig 138: Oceania Market Y-o-Y Growth Projections, By Country to 2025 to 2035
Fig 139: Oceania Market Attractiveness Index, By Country to 2025 to 2035
Fig 140: United States Market share by Design, 2025
Fig 141: United States Market share by Property, 2025
Fig 142: United States Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 143: United States Market Share by End User, 2025
Fig 144: Canada Market share by Design, 2025
Fig 145: Canada Market share by Property, 2025
Fig 146: Canada Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 147: Canada Market Share by End User, 2025
Fig 148: Germany Market share by Design, 2025
Fig 149: Germany Market share by Property, 2025
Fig 150: Germany Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 151: Germany Market Share by End User, 2025
Fig 152: United Kingdom Market share by Design, 2025
Fig 153: United Kingdom Market share by Property, 2025
Fig 154: United Kingdom Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 155: United Kingdom Market Share by End User, 2025
Fig 156: France Market share by Design, 2025
Fig 157: France Market share by Property, 2025
Fig 158: France Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 159: France Market Share by End User, 2025
Fig 160: Russia Market share by Design, 2025
Fig 161: Russia Market share by Property, 2025
Fig 162: Russia Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 163: Russia Market Share by End User, 2025
Fig 164: Spain Market share by Design, 2025
Fig 165: Spain Market share by Property, 2025
Fig 166: Spain Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 167: Spain Market Share by End User, 2025
Fig 168: Italy Market share by Design, 2025
Fig 169: Italy Market share by Property, 2025
Fig 170: Italy Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 171: Italy Market Share by End User, 2025
Fig 172: China Market share by Design, 2025
Fig 173: China Market share by Property, 2025
Fig 174: China Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 175: China Market Share by End User, 2025
Fig 176: Japan Market share by Design, 2025
Fig 177: Japan Market share by Property, 2025
Fig 178: Japan Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 179: Japan Market Share by End User, 2025
Fig 180: South Korea Market share by Design, 2025
Fig 181: South Korea Market share by Property, 2025
Fig 182: South Korea Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 183: South Korea Market Share by End User, 2025
Fig 184: India Market share by Design, 2025
Fig 185: India Market share by Property, 2025
Fig 186: India Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 187: India Market Share by End User, 2025
Fig 188: Singapore Market share by Design, 2025
Fig 189: Singapore Market share by Property, 2025
Fig 190: Singapore Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 191: Singapore Market Share by End User, 2025
Fig 192: Indonesia Market share by Design, 2025
Fig 193: Indonesia Market share by Property, 2025
Fig 194: Indonesia Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 195: Indonesia Market Share by End User, 2025
Fig 196: Thailand Market share by Design, 2025
Fig 197: Thailand Market share by Property, 2025
Fig 198: Thailand Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 199: Thailand Market Share by End User, 2025
Fig 200: Brazil Market share by Design, 2025
Fig 201: Brazil Market share by Property, 2025
Fig 202: Brazil Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 203: Brazil Market Share by End User, 2025
Fig 204: Mexico Market share by Design, 2025
Fig 205: Mexico Market share by Property, 2025
Fig 206: Mexico Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 207: Mexico Market Share by End User, 2025
Fig 208: Turkey Market share by Design, 2025
Fig 209: Turkey Market share by Property, 2025
Fig 210: Turkey Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 211: Turkey Market Share by End User, 2025
Fig 212: GCC Countries Market share by Design, 2025
Fig 213: GCC Countries Market share by Property, 2025
Fig 214: GCC Countries Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 215: GCC Countries Market Share by End User, 2025
Fig 216: South Africa Market share by Design, 2025
Fig 217: South Africa Market share by Property, 2025
Fig 218: South Africa Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 219: South Africa Market Share by End User, 2025
Fig 220: Australia Market share by Design, 2025
Fig 221: Australia Market share by Property, 2025
Fig 222: Australia Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 223: Australia Market Share by End User, 2025
Fig 224: New Zealand Market share by Design, 2025
Fig 225: New Zealand Market share by Property, 2025
Fig 226: New Zealand Market Value (US$ Mn) and Forecast 2025 to 2035
Fig 227: New Zealand Market Share by End User, 2025
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the central venous catheters market?
The market is expected to reach USD 1.54 billion in 2025.
What is the outlook for the central venous catheters market?
The industry is projected to grow to USD 2.63 billion by 2035.
Which country is expected to see the fastest growth in this market?
China is anticipated to experience a 7.2% CAGR during the forecast period.
Which product segment dominates the central venous catheter market?
Multi-lumen and triple-lumen catheters are widely used in the market.
Who are the key players in the central venous catheters market?
Leading companies include Medtronic Plc, Becton, Dickinson and Company, Teleflex Incorporated, Smiths Medical, Inc., AngioDynamics Inc., Amecath, Vygon Ltd., ZOLL Medical Corporation, Bactiguard AB, and COOK MEDICAL LLC.
Central Venous Catheters (CVCs) Market